Anti-amyloid drugs have been considered game-changing for Alzheimer's, but an extensive review has revealed that the drugs ...

These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent ...

Acosta Group reports GLP-1 users are driving healthier eating, new product demand and labeling challenges, reshaping food, ...

Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...

Placebo effects, in which patients experience relief without therapeutic treatment, increasingly have been considered as potentially powerful clinical treatments for ailments such as depression and ...

The drug’s distributor, Viatris, said it was recalling one lot containing 51 bottles of 3 milligram extended release tablets.

A medical oncologist called the late-stage clinical trial results "remarkable," though Sasse said the drug means his body ...

Rezdiffra (resmetirom) is a brand-name drug prescribed for a type of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH) ...